ehave-logo.png
FDA Grants Ehave Consent to Proceed With Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder
15 déc. 2022 08h00 HE | Ehave
MIAMI, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, announced today...
Vantage Market Research.png
Medical Document Management Systems Market to Reach $1223.88 Billion by 2028 - Upsurge in Number of Patients Visiting Hospitals to Surge Demand - Exclusive Report by Vantage Market Research
31 janv. 2022 04h58 HE | Vantage Market Research
WASHINGTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- The Global Medical Document Management Systems Market is estimated to reach USD 1223.88 Billion by 2028, displaying a compound annual growth rate (CAGR)...
ehave-logo.png
Ehave Expands Dashboard Capabilities to Include Decentralized Trials and Virtual Studies
02 juin 2021 08h30 HE | Ehave
MIAMI, June 02, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, today...
CEOS LOGO.png
CeCors, Inc. to Acquire 100% of Medical Records and Data Company
05 août 2019 09h00 HE | CeCors, Inc.
LAS VEGAS, NV, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CeCors, Inc. (OTC PINK:CEOS); a Company focused on the Health & Technology Sector as well as other Emerging Technologies, is...